Anita Afzali, MD, MPH, FACG, is an associate professor of clinical medicine and a gastroenterologist that specializes in inflammatory bowel disease (IBD) at The Ohio State University Wexner Medical Center. Dr Afzali is currently the director of operations for the Division of Gastroenterology, Hepatology and Nutrition, as well as the medical director of the OSU Inflammatory Bowel Disease Center. Also, she holds the Abercrombie & Fitch Endowed Chair in Inflammatory Bowel Disease. Dr Afzali received her medical degree and completed her internal medicine residency and gastroenterology fellowship at the University of Washington in Seattle, WA. While in fellowship, Dr Afzali worked in outcomes research and epidemiology, and also graduated with a master’s degree in public health. Her subspecialty training includes a 1-year advanced IBD fellowship at the University of Washington, prior to becoming faculty. While practicing at the University of Washington – Harborview Medical Center, Dr Afzali served as director of the IBD program and associate medical director of the gastroenterology clinics. Dr Afzali is board certified in internal medicine and gastroenterology.
Dr Afzali’s research interests include, clinical outcomes and association of bowel and joint disease, influence of the metabolic syndrome, and impact of race/ethnicity in IBD, as well as pharmacoeconomics, pediatric-to-adult transition, and women of childbearing age with IBD. She is also extensively involved in IBD clinical trials for investigational therapies. Dr Afzali has extensive peer-reviewed publications and has been an invited lecturer on national and international programs, and serves on several international advisory boards and committees, including serving as co-chair of the Crohn’s & Colitis National Professional Education Committee and member of the ACG Minority Affairs and Cultural Diversity Committee.